Taxhal 300mg Injection

About

Taxhal 300mg Injection is a high-dose antineoplastic agent from the taxane family, designed for intravenous administration in the treatment of various advanced cancers. Its primary mechanism of action involves disrupting the microtubule dynamics within cancer cells. By binding to tubulin, Taxhal promotes the assembly of microtubules and prevents their disassembly, leading to the formation of stable, non-functional microtubule bundles. This abnormal stabilization arrests cells in the G2/M phase of the cell cycle, inhibiting cell division and ultimately inducing apoptosis. This potent cytotoxic effect makes it a critical component in aggressive chemotherapy regimens for specific malignancies.

Uses

• Treatment of advanced ovarian cancer
• Management of metastatic breast cancer
• Therapy for non-small cell lung cancer
• Used in gastric adenocarcinoma

Directions For Use

Administered via intravenous infusion by a qualified healthcare professional. Dosage and schedule are strictly determined by the oncologist.

Benefits

• Potent anti-tumor activity in advanced cancers
• Effective in inducing significant tumor regression
• Can improve overall survival in specific indications
• Often used in refractory or aggressive cases
• Part of aggressive treatment protocols for high-burden disease
• Well-studied and established in oncology guidelines

Side Effects

• Severe myelosuppression (neutropenia, anemia, thrombocytopenia)
• Significant peripheral neuropathy (nerve damage)
• Severe alopecia (complete hair loss)
• Nausea and vomiting (often severe)
• Profound fatigue and asthenia
• Mucositis (severe mouth and throat sores)
• Hypersensitivity reactions (potentially life-threatening)
• Fluid retention (severe edema)
• Arthralgia (joint pain) and myalgia (muscle pain)
• Diarrhea
• Skin rash and desquamation
• Increased risk of infection

Safety Measures

• Alcohol - Avoid alcohol completely due to potential for exacerbating gastrointestinal side effects and liver toxicity.
• Pregnancy - Absolutely contraindicated. Highly teratogenic. Strict contraception is mandatory for both male and female patients.
• Breastfeeding - Contraindicated. The drug is likely excreted in breast milk and poses a significant risk to the infant.
• Liver - Extreme caution and significant dose reduction required in patients with hepatic impairment due to increased risk of severe toxicity.
• Kidney - Monitor renal function closely. Dose adjustments may be necessary in severe renal dysfunction, although primarily metabolized by the liver.
• Lung - Close monitoring for pulmonary complications, including interstitial lung disease, is essential, especially in patients with compromised respiratory function.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.